BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma

Published:2022-11 Issue:11 Volume:30 Page:3394-3413
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zhang Ming^ORCID,Wang Ganping^ORCID,Ma Zhikun,Xiong Gan^ORCID,Wang Wenjin^ORCID,Huang Zhengxian,Wan Yuehan,Xu Xiuyun,Hoyle Rosalie G.^ORCID,Yi Chen,Hou Jinsong,Liu Xiqiang,Chen Demeng,Li Jiong^ORCID,Wang Cheng^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference57 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA. Cancer J. Clin.,2018

2. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma;Hedberg;J. Clin. Invest.,2016

3. The promise of immunotherapy in head and neck squamous cell carcinoma;Economopoulou;Ann. Oncol.,2016

4. Elements of cancer immunity and the cancer–immune set point;Chen;Nature,2017

5. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study;Wolchok;Lancet Oncol.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives;Biomarker Research;2024-07-30

2. BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia;JCI Insight;2024-05-22

3. The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update;OncoTargets and Therapy;2024-05

4. ¹³¹I Induced In Vivo Proteolysis by Photoswitchable azoPROTAC Reinforces Internal Radiotherapy;Small;2024-04-28

5. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review);Oncology Reports;2024-04-12